Qritive
Shriya Kumar is an experienced professional in strategy and business development, currently serving at Qritive since November 2022. Prior to this role, Shriya held the position of Account Lead at Babylon from March 2020 to August 2022, and worked at IBM from July 2014 to November 2019 as a Client Success Manager, contributing to initiatives that leverage Artificial Intelligence for healthcare improvements. Shriya's prior experience includes roles as a Business Development Executive at IBM Research Healthcare and Life Sciences, a Business Development Consultant at the Office of Technology Management at UIC, and a Research Project Manager at the Metabolites Biology Lab at the National University of Singapore. Educational qualifications include a Master of Science in Biotechnology from Penn State University and a Master of Science in Intellectual Property Management from the Chicago-Kent College of Law.
This person is not in any teams
This person is not in any offices
Qritive
Qritive makes cancer diagnosis fast, cheap, and accurate. Qritive develops AI-powered solutions that enable histopathologic diagnosis of cancer at scale. Our clinical-decision support system for pathologists unlocks efficiency and quality gain in diagnosis, which results in better patient outcome. It includes AI Modules, an Image Management System platform (Pantheon), and a network of pathologists on-demand for services (annotations, 2nd opinion...) Our digital pathology platform has been used by several healthcare institutions in Singapore, India, Morocco, UAE, and USA, and the results have been presented at various events and journals: USCAP 2023 (deep learning on prostate biopsies), 2022 (Ki-67 on Sarcomas), and 2021 (colorectal malignancies), or Nature Scientific Report.